CapForce Inc. CFOR
OTC · stock · Services-Medical Laboratories · website · IPO 2015-05-05
CapForce Inc. statistics & valuation
Market cap$24.8M
P / E1.0×
P / S0.8×
P / B0.8×
Net margin78.2%
Return on equity74.1%
FCF margin-4.1%
Return on capital71.7%
Graham number +178.3%$12.80
Market cap as of 2026-07-02. Multiples are price-derived and refreshed daily; everything else from the latest financial reports. The Graham number is Benjamin Graham's rough maximum fair value ($12.80); a green figure means the price is below it.
Profitability & efficiency
Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating margin | 79.6% | 6.2% | -899.5% | -1325.8% | -540.5% | -539.1% | -350.7% | -447.3% | -475.4% | -472.2% |
| Net margin | 78.2% | 230.8% | -955.7% | -1430.0% | -808.3% | -621.9% | -355.8% | -453.7% | -480.2% | -476.1% |
| FCF margin | -4.1% | — | -442.3% | -807.0% | -544.9% | -558.2% | -329.8% | -380.9% | -454.1% | -431.6% |
| Return on assets | 62.1% | 121.6% | -1735.6% | -144.4% | -48.6% | -52.7% | -119.4% | -149.4% | -232.9% | -213.3% |
| Return on equity | 74.1% | 162.5% | 282.6% | -492.2% | -84.4% | -123.7% | -289.9% | -404.0% | -1100.6% | -605.1% |
| Debt / equity | — | — | — | 0.64× | 0.17× | 0.91× | 0.08× | — | — | — |
| Current ratio | 0.22 | 4.18 | 0.14 | 1.01 | 2.00 | 2.29 | 1.35 | 1.32 | 0.73 | 1.08 |
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.